TCRT: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	0	0	0	2,000	0	4,000
Research and development	427,000	469,000	185,000	347,000	143,000	180,000
Selling, general and administrative	585,000	718,000	854,000	747,000	1M	990,000
Operating expenses	1M	1M	1M	1M	1M	1M
Operating income	−1M	−1M	−1M	−1M	−1M	−1M
Interest expense	—	—	—	—	—	0
Net income	−1M	−1M	−1M	−1M	−1M	−1M
Earnings per share	−0.59	−0.55	−0.63	−0.67	−0.70	−0.71
Earnings per share, diluted	−0.59	−0.55	−0.63	−0.67	−0.70	−0.71
Weighted average shares	2M	2M	2M	2M	2M	2M
Weighted average shares, diluted	2M	2M	2M	2M	2M	2M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	354,000	1M	2M	3M	319,000	1M	2M	2M
Receivables	0	3,000	0	2,000	2,000	5,000	0	4,000
Current assets	970,000	2M	3M	4M	1M	3M	4M	5M
Property, plant and equipment	82,000	91,000	97,000	—	—	0	0	0
Total assets	2M	3M	4M	5M	2M	3M	4M	5M
Current liabilities	595,000	813,000	921,000	1M	1M	692,000	826,000	907,000
Total liabilities	595,000	813,000	921,000	1M	1M	692,000	826,000	907,000
Equity	1M	2M	3M	4M	1M	2M	3M	4M
Shares outstanding	2M	2M	2M	2M	2M	2M	2M	2M
Shares issued	2M	2M	2M	2M	2M	2M	2M	2M

Metric	31/03/2026	31/03/2025
Operating cash flow	−1M	−772,000
Depreciation and amortisation	8,000	0